Privately held specialty pharmaceutical company Revive Pharmaceuticals (not to be confused with Revive Therapeutics Ltd. (TSXV: RVV), a clinical-stage company developing novel therapies for gout, sleep apnea and rare diseases) will continue to operate without the treatment.
Concordia CEO Mark Thompson explained the reasoning behind the pickup.
“The acquisition of Donnatal® represents an important advancement in the execution of Concordia’s legacy product strategy, providing substantial and sustainable revenue going forward,” he said. “In addition, we believe that Donnatal will have a significant and positive impact on Concordia’s net earnings and EBITDA.”
According to the National Institutes of Health, some 30% of Americans suffer from IBS at some time in their lives. The condition is second only to the common cold as a cause of absenteeism from work. IBS is one of the top 10 reasons for physician visits and the second most frequently encountered diagnosis in clinical practice, accounting for more physician visits than any symptoms other than those for respiratory tract infections.
At press time, shares of Concordia Healthcare were up 5.4% to $16.69.
Microsoft's (Microsoft Stock Quote, Chart, News, Analysts, Financials NASDAQ:MSFT) strong cash flow and balance sheet make it an attractive investment… [Read More]
Growing demand for independent space launch facilities and increased defence spending could strengthen the outlook for Maritime Launch Services (Maritime… [Read More]
Rubicon Organics’ (Rubicon Organics Stock Quote, Chart, News, Analysts, Financials TSXV:ROMJ) slower-than-expected expansion of its Cascadia production facility has prompted… [Read More]
Persistently high fuel prices and growing pressure on Transat A.T.’s (Transat A.T. Stock Quote, Chart, News, Analysts, Financials TSX:TRZ) balance… [Read More]
Target’s (Target Corporation Stock Quote, Chart, News, Analysts, Financials NYSE:TGT) stronger-than-expected third-quarter results and improved earnings outlook have failed to… [Read More]
Propel Holdings’ (Propel Holdings Stock Quote, Chart, News, Analysts, Financials TSX:PRL) expanding lending platform and use of artificial intelligence to… [Read More]